Addressing Global Reproductive Challenges: Strategic Growth in the Infertility Market Driven by Assisted Reproductive Technologies (ART), Genetic Screening, and Fertility Preservation
The persistent global trends of delayed parenthood, increasing prevalence of reproductive disorders related to lifestyle and environment, and growing public openness towards fertility assistance have positioned the Infertility Market as a sector experiencing robust and sustained growth. The market provides a comprehensive range of solutions, including diagnostic testing, various drug therapies (e.g., ovulation induction drugs), and the cornerstone Assisted Reproductive Technologies (ART) such as In Vitro Fertilization (IVF) and Intra-Cytoplasmic Sperm Injection (ICSI). Primary drivers include the continuous increase in the average age of first-time mothers in developed economies and a sustained reduction in the social and cultural stigma associated with fertility treatment, encouraging more couples and individuals to seek professional medical assistance. The resulting consistent improvements in ART success rates, driven by technological enhancements, are a critical confidence-booster,…